Tarsus Pharmaceuticals, Inc.’s Post

Celebrating a milestone! It's been one year since the FDA approved our treatment for Demodex blepharitis, marking a significant step forward in eye care. We are always happy to celebrate a win for patients, and as we reflect on this achievement, we're excited about the future and our ongoing commitment to improving the lives of those affected by this eyelid disease.

Congratulations on the milestone! It’s fantastic to see your dedication to advancing eye care and improving patient outcomes. Here’s to many more successes ahead! #EyeCare #PatientFirst

Like
Reply

Wonderful!

Like
Reply
Doug Brown

VP Business Development at BIONICAL Solutions

3mo

Congrats to Team Tarsus!

Like
Reply
Jason Alongi

Senior Director Consumer Marketing - Tarsus

3mo

So exciting!

Like
Reply
Darlene Slocum

ARS Pharmceuticals Specialty Account Manager

3mo

Congrats!

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics